Volume 24, Issue 5 pp. E201-E206

Depressive symptoms and mortality in lung transplant

Donna M. Evon

Donna M. Evon

Department of Medicine, University of North Carolina at Chapel Hill

Search for more papers by this author
Eileen J. Burker

Eileen J. Burker

Department of Psychiatry, University of North Carolina at Chapel Hill

Department of Allied Health Sciences, University of North Carolina at Chapel Hill

Search for more papers by this author
Joseph A. Galanko

Joseph A. Galanko

Department of Medicine, University of North Carolina at Chapel Hill

Search for more papers by this author
Eric Dedert

Eric Dedert

Department of Psychiatry, University of North Carolina at Chapel Hill

Search for more papers by this author
Thomas M. Egan

Thomas M. Egan

Department of Cardiothoracic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Search for more papers by this author
First published: 28 April 2010
Citations: 24
Corresponding author: Eileen J. Burker, PhD, CRC, Division of Rehabilitation Counseling and Psychology, Departments of Allied Health Sciences and Psychiatry, CB #7205, 2087 Bondurant Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7205, USA.
Tel.: +919 966 9125 ; fax: +919 966 9007; e-mail: [email protected]

The project described was supported, in part, by Award Number KL2RR025746 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.Joe Galanko is supported by NIH Grants DK 034987 and DK 056350.

Abstract

Evon DM, Burker EJ, Galanko JA, Dedert E, Egan TM. Depressive symptoms and mortality in lung transplant.
Clin Transplant 2010 DOI: 10.1111/j.1399-0012.2010.01236.x. © 2010 John Wiley & Sons A/S.

Abstract: Objective: To determine whether depressive symptoms predicted survival before and after lung transplantation. We hypothesized that depressive symptoms might predict survival of wait-listed patients, but would not predict survival post-transplant.

Methods: This was a prospective, longitudinal study. Participants completed the Beck Depression Inventory pre-transplant. Pre-transplant survival analyses were conducted (n = 124) based on time from list date, to death, transplant, or censoring, if still alive. Post-transplant survival analyses were conducted (n = 76) based on time from transplant, to death or censoring. Cox proportional hazards regression analyses were utilized.

Results: In the unadjusted model, depressive symptoms predicted mortality for candidates awaiting lung transplant (p = 0.02); however, once models were adjusted for demographics and pulmonary status, the relationship between depressive symptoms and mortality rates was attenuated (p > 0.05). Depressive symptoms did not predict survival after lung transplant (p > 0.05).

Conclusions: Pre-transplant depressive symptoms were associated with mortality among lung transplant candidates in an unadjusted model and a model fit with demographics and forced expiratory volume in one second. Depressive symptoms do not exert an independent effect when forced expiratory vital capacity is added. Depressive symptoms do not predict mortality after transplant. Future studies need to determine whether pre-transplant psychosocial characteristics confer a greater risk for poorer transplant outcomes.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.